Back to search
FDAFDA · Food and drugs·Recall number D-599-2013

Fentanyl Transdermal System, 50 mcg/h, 1 system per pouch (NDC 0591-3212-54), packaged in 5-count systems per box (NDC 0591-3212-72), Rx only, Manufactured by Watson Laboratories, Inc, Corona, CA, 92880 USA; Distributed by: Watson Pharma, Inc.

Published June 19, 2013 · Recall initiated: June 3, 2013

Summary

FDA records drug Class III recall D-599-2013, published June 19, 2013 and initiated June 3, 2013. Recalling firm: Actavis; Status: Terminated; Reported quantity: 98,952 boxes; Lot: Lot #: Patch 453658; Carton 453658A, Exp 09/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis
Distributor
Nationwide
Lot
Lot #: Patch 453658; Carton 453658A, Exp 09/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl Transdermal System, 50 mcg/h, 1 system per pouch (NDC 0591-3212-54), packaged in 5-count systems per box (NDC 0591-3212-72), Rx only, Manufactured by Watson Laboratories, Inc, Corona, CA, 92880 USA; Distributed by: Watson Pharma, Inc. recalled?

Yes. FDA published recall D-599-2013 on June 19, 2013. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter